The Wilms' tumor gene Wt1 is required for normal development of the retina

被引:122
作者
Wagner, KD
Wagner, N
Vidal, VPI
Schley, G
Wilhelm, D
Schedl, A
Englert, C
Scholz, H [1 ]
机构
[1] Humboldt Univ, Johannes Muller Inst Physiol, Berlin, Germany
[2] Humboldt Univ, Med Klin 1, Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Dev Genet Grp, Berlin, Germany
[4] Kernforschungszentrum Karlsruhe GmbH, Inst Genet & Toxikol, D-7500 Karlsruhe, Germany
关键词
apoptosis; POU-domain factors; retina development; retinal ganglion cells; Wilms' tumor gene;
D O I
10.1093/emboj/21.6.1398
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wilms' tumor gene Wt1 is known for its important functions during genitourinary and mesothelial formation. Here we show that Wt1 is necessary for neuronal development in the vertebrate retina. Mouse embryos with targeted disruption of Wt1 exhibit remarkably thinner retinas than age-matched wild-type animals. A large fraction of retinal ganglion cells is lost by apoptosis, and the growth of optic nerve fibers is severely disturbed. Strikingly, expression of the class IV POU-domain transcription factor Pou4f2 (formerly Brn-3b), which is critical for the survival of most retinal ganglion cells, is lost in Wt1(-/-) retinas. Forced expression of Wt1 in cultured cells causes an up-regulation of Pou4f2 mRNA. Moreover, the Wt1(-KTS) splice variant can activate a reporter construct carrying 5'-regulatory sequences of the human POU4F2. The lack of Pou4f2 and the ocular defects in Wt1(-/-) embryos are rescued by transgenic expression of a 280 kb yeast artificial chromosome carrying the human WT1 gene. Taken together, our findings demonstrate a continuous requirement for Wt1 in normal retina formation with a critical role in Pou4f2-dependent ganglion cell differentiation.
引用
收藏
页码:1398 / 1405
页数:8
相关论文
共 49 条
[1]   THE EXPRESSION OF THE WILMS-TUMOR GENE, WT1, IN THE DEVELOPING MAMMALIAN EMBRYO [J].
ARMSTRONG, JF ;
PRITCHARDJONES, K ;
BICKMORE, WA ;
HASTIE, ND ;
BARD, JBL .
MECHANISMS OF DEVELOPMENT, 1993, 40 (1-2) :85-97
[2]  
BENNINGTON JL, 1975, ATLAS TUMOR PATHOL 2
[3]   ANIRIDIA, WILMS TUMOR AND HUMAN-CHROMOSOME 11 [J].
BICKMORE, WA ;
HASTIE, ND .
OPHTHALMIC PAEDIATRICS AND GENETICS, 1989, 10 (04) :229-248
[4]  
Braissant O., 1998, BIOCHEMICA, V1, P10
[5]   ISOLATION, CHARACTERIZATION, AND EXPRESSION OF THE MURINE WILMS-TUMOR GENE (WT1) DURING KIDNEY DEVELOPMENT [J].
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
GLASER, T ;
HOUSMAN, DE .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) :1707-1712
[6]   Cell fate determination in the vertebrate retina [J].
Cepko, CL ;
Austin, CP ;
Yang, XJ ;
Alexiades, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :589-595
[7]   WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes [J].
Davies, RC ;
Calvio, C ;
Bratt, E ;
Larsson, SH ;
Lamond, AI ;
Hastie, ND .
GENES & DEVELOPMENT, 1998, 12 (20) :3217-3225
[8]  
Englert C, 1997, CANCER RES, V57, P1429
[9]   Truncated WT1 mutants alter the subnuclear localization of the wild-type protein [J].
Englert, C ;
Vidal, M ;
Maheswaran, S ;
Ge, YM ;
Ezzell, RM ;
Isselbacher, KJ ;
Haber, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :11960-11964
[10]   WT1 SUPPRESSES SYNTHESIS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND INDUCES APOPTOSIS [J].
ENGLERT, C ;
HOU, X ;
MAHESWARAN, S ;
BENNETT, P ;
NGWU, C ;
RE, GG ;
GARVIN, AJ ;
ROSNER, MR ;
HABER, DA .
EMBO JOURNAL, 1995, 14 (19) :4662-4675